Reduction of door-to-balloon time by new performance processes in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Angiology

Volumn 62, Issue 3, 2011, Pages 257-264

  Nam, Young Hee ^a   Cha, Kwang Soo ^b   Kim, Jeong Hwan ^a   Park, Sun Yi ^a   Park, Tae Ho ^a   Kim, Moo Hyun ^a   Kim, Young Dae ^a  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

door to balloon time; myocardial infarction; primary percutaneous coronary intervention; reperfusion

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILE PHONE; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STATISTICS, NONPARAMETRIC; TELEPHONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952801178     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710380682     Document Type: Article

References (29)

1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction). Circulation. 2004 ; 110 (5). 588-636. (Pubitemid 39036178)
2. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003 ; 42 (6). 991-997. (Pubitemid 37108581)
3. Antoniucci D., Valenti R., Migliorini A., et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2002 ; 89 (11). 1248-1252. (Pubitemid 34606883)
4. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000 ; 283 (22). 2941-2947. (Pubitemid 30414505)
5. Brodie BR, Stone GW, Morice MC, et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol. 2001 ; 88 (10). 1085-1090. (Pubitemid 33043836)
6. Zijlstra F., Patel A., Jones M., et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 2002 ; 23 (7). 550-557. (Pubitemid 35192202)
7. McNamara RL, Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006 ; 47 (11). 2180-2186. (Pubitemid 43810139)
8. Keeley EC, Boura JA, Grines CL Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003 ; 361 (9351). 13-20. (Pubitemid 36050955)
9. Andersen HR, Nielsen TT, Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003 ; 349 (8). 733-742. (Pubitemid 37010777)
10. Bradley EH, Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006 ; 355 (22). 2308-2320. (Pubitemid 44837779)
11. Kraft PL, Newman S., Hanson D., Anderson W., Bastani A. Emergency physician discretion to activate the cardiac catheterization team decreases door-to-balloon time for acute ST-elevation myocardial infarction. Ann Emerg Med. 2007 ; 50 (5). 520-526. (Pubitemid 47600380)
12. Boersma E., Mercado N., Poldermans D., Gardien M., Vos J., Simoons ML Acute myocardial infarction. Lancet. 2003 ; 361 (9360). 847-858. (Pubitemid 36331851)
13. Barron HV, Bowlby LJ, Breen T., et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation. 1998 ; 97 (12). 1150-1156. (Pubitemid 28152888)
14. Eagle KA, Goodman SG, Avezum A., Budaj A., Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002 ; 359 (9304). 373-377. (Pubitemid 34158943)
15. Ribichini F., Ferrero V., Wijns W. Reperfusion treatment of ST elevation acute myocardial infarction. Prog Cardiovasc Dis. 2004 ; 47 (2). 131-157. (Pubitemid 39600947)
16. Kleinschmidt K., Brady WJ Acute coronary syndromes: an evidence based review and outcome-optimizing guidelines for patients with and without procedural coronary intervention (PCI). Part III: fibrinolytic therapy, procedural coronary intervention, multi-modal approaches, and medical prophylaxis with low molecular weight heparins. Hospital Medicine Consensus Reports. Atlanta, GA: American Health Consultants; 2001.
17. Brodie BR, Hansen C., Stuckey TD, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol. 2006 ; 47 (2). 289-295. (Pubitemid 43063244)
18. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation. 1999 ; 100 (1). 14-20. (Pubitemid 29297934)
19. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO Investigators. N Engl J Med. 1993 ; 329 (10). 673-682.
20. Boersma E., Maas AC, Deckers JW, Simoons ML Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996 ; 348 (9030). 771-775. (Pubitemid 26308479)
21. De Luca G., Suryapranata H., Ottervanger JP, Antman EM Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004 ; 109 (10). 1223-1225. (Pubitemid 38372780)
22. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000 ; 36 (7). 2056-2063.
23. Goff DC Jr, Feldman HA, McGovern PG, et al. Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT Trial. Rapid Early Action for Coronary Treatment (REACT) Study Group. Am Heart J. 1999 ; 138 (6 pt 1). 1046-1057.
24. Nallamothu BK, Bates ER Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything ? Am J Cardiol. 2003 ; 92 (7). 824-826. (Pubitemid 37163578)
25. Nissen SE, Brush JE Jr, Krumholz HM President's page: GAP-D2B: an alliance for quality. J Am Coll Cardiol. 2006 ; 48 (9). 1911-1912. (Pubitemid 44648640)
26. What is D2B? http://www.d2balliance.org/WhatisD2B/D2BCoreStrategies/ tabid/145/default.aspx. Accessed March 15, 2007.
27. Jacoby J., Axelband J., Patterson J., Belletti D., Heller M. Cardiac cath lab activation by the emergency physician without prior consultation decreases door-to-balloon time. J Invasive Cardiol. 2005 ; 17 (3). 154-155. (Pubitemid 41724702)
28. Thatcher JL, Gilseth TA, Adlis S. Improved efficiency in acute myocardial infarction care through commitment to emergency department-initiated primary PCI. J Invasive Cardiol. 2003 ; 15 (12). 693-698. (Pubitemid 37549286)
29. Brener SJ, Zeymer U., Adgey AA, et al. Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the Integrilin and low-dose Thrombolysis in Acute Myocardial Infarction(INTRO AMI) trial. J Am Coll Cardiol. 2002 ; 39 (3). 377-386. (Pubitemid 34117492)